body·mind·state
← Back to Events
🔬 Clinical Trial

New Trial: RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

📅 2026-06-26

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo....

BMS
Body Mind State EditorialJune 26, 2026

Trial Overview

NCT ID: NCT07489651 Phase: PHASE2 Enrollment Target: 64 Status: Recruiting

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.

Why This Matters

[Draft — editorial context needed]

Source

Continue Reading

🔬 Clinical Trial

New Trial: Feasibility of Breathwork Intervention With Older Adults After Knee Surgery

Postoperative complications after surgical procedures, including following total knee arthroplasty (TKA), have a negative impact on the health and well-being of surgical patients. Older adults (≥65 years) are particularly vulnerable to postoperative...

1 min read🔬 Clinical Trial

New Trial: Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

The core objective of this study is to enhance the translational potential of this electroencephalogram (EEG) biomarker by using ketamine(KET)-induced gamma potentiation as a prognostic marker of 4-week treatment outcome. Previous research focused ex...

1 min read🔬 Clinical Trial

New Trial: Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms

MAGNETS is a prospective, randomized, parallel-design, sham-controlled clinical trial of accelerated, functional magnetic resonance imaging (fMRI)-guided intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (dlPFC)...

1 min read